These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 39105414)
1. SiMPl-GS: Advancing Cell Line Development via Synthetic Selection Marker for Next-Generation Biopharmaceutical Production. Yoon C; Lee EJ; Kim D; Joung S; Kim Y; Jung H; Kim YG; Lee GM Adv Sci (Weinh); 2024 Oct; 11(38):e2405593. PubMed ID: 39105414 [TBL] [Abstract][Full Text] [Related]
2. Attenuated glutamine synthetase as a selection marker in CHO cells to efficiently isolate highly productive stable cells for the production of antibodies and other biologics. Lin PC; Chan KF; Kiess IA; Tan J; Shahreel W; Wong SY; Song Z MAbs; 2019 Jul; 11(5):965-976. PubMed ID: 31043114 [TBL] [Abstract][Full Text] [Related]
3. Development of a highly-efficient CHO cell line generation system with engineered SV40E promoter. Fan L; Kadura I; Krebs LE; Larson JL; Bowden DM; Frye CC J Biotechnol; 2013 Dec; 168(4):652-8. PubMed ID: 23994266 [TBL] [Abstract][Full Text] [Related]
4. Improving the efficiency of CHO cell line generation using glutamine synthetase gene knockout cells. Fan L; Kadura I; Krebs LE; Hatfield CC; Shaw MM; Frye CC Biotechnol Bioeng; 2012 Apr; 109(4):1007-15. PubMed ID: 22068567 [TBL] [Abstract][Full Text] [Related]
5. Enhancing CHO cell productivity through a dual selection system using Aspg and Gs in glutamine free medium. Ha TK; Òdena A; Karottki KJC; Kim CL; Hefzi H; Lee GM; Faustrup Kildegaard H; Nielsen LK; Grav LM; Lewis NE Biotechnol Bioeng; 2023 Apr; 120(4):1159-1166. PubMed ID: 36562657 [TBL] [Abstract][Full Text] [Related]
6. Glutamine synthetase (GS) knockout (KO) using CRISPR/Cpf1 diversely enhances selection efficiency of CHO cells expressing therapeutic antibodies. Srila W; Baumann M; Riedl M; Rangnoi K; Borth N; Yamabhai M Sci Rep; 2023 Jun; 13(1):10473. PubMed ID: 37380701 [TBL] [Abstract][Full Text] [Related]
7. Attenuation of glutamine synthetase selection marker improves product titer and reduces glutamine overflow in Chinese hamster ovary cells. Sacco SA; Tuckowski AM; Trenary I; Kraft L; Betenbaugh MJ; Young JD; Smith KD Biotechnol Bioeng; 2022 Jul; 119(7):1712-1727. PubMed ID: 35312045 [TBL] [Abstract][Full Text] [Related]
8. Improvement of the efficiency and quality in developing a new CHO host cell line. Huhn SC; Ou Y; Tang X; Jiang B; Liu R; Lin H; Du Z Biotechnol Prog; 2021 Sep; 37(5):e3185. PubMed ID: 34142466 [TBL] [Abstract][Full Text] [Related]
9. Optimization of cell line development in the GS-CHO expression system using a high-throughput, single cell-based clone selection system. Nakamura T; Omasa T J Biosci Bioeng; 2015 Sep; 120(3):323-9. PubMed ID: 25792187 [TBL] [Abstract][Full Text] [Related]
10. Reduction of ammonia and lactate through the coupling of glutamine synthetase selection and downregulation of lactate dehydrogenase-A in CHO cells. Noh SM; Park JH; Lim MS; Kim JW; Lee GM Appl Microbiol Biotechnol; 2017 Feb; 101(3):1035-1045. PubMed ID: 27704181 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive characterization of glutamine synthetase-mediated selection for the establishment of recombinant CHO cells producing monoclonal antibodies. Noh SM; Shin S; Lee GM Sci Rep; 2018 Mar; 8(1):5361. PubMed ID: 29599455 [TBL] [Abstract][Full Text] [Related]
12. Superfluous glutamine synthetase activity in Chinese Hamster Ovary cells selected under glutamine limitation is growth limiting in glutamine-replete conditions and can be inhibited by serine. Maralingannavar V; Parmar D; Panchagnula V; Gadgil M Biotechnol Prog; 2019 Sep; 35(5):e2856. PubMed ID: 31148368 [TBL] [Abstract][Full Text] [Related]
13. Limitations to the development of recombinant human embryonic kidney 293E cells using glutamine synthetase-mediated gene amplification: Methionine sulfoximine resistance. Yu DY; Noh SM; Lee GM J Biotechnol; 2016 Aug; 231():136-140. PubMed ID: 27288593 [TBL] [Abstract][Full Text] [Related]
14. [Construction of an anti-apoptosis CHO cell line for biopharmaceutical production]. Lai DZ; Fu L; Yu CM; Qi LQ; Weng SJ; Yu T; Wang HT; Chen W Sheng Wu Gong Cheng Xue Bao; 2003 May; 19(3):322-6. PubMed ID: 15969015 [TBL] [Abstract][Full Text] [Related]
15. An attempt to add biological functions by genetic engineering in order to produce high-performance bioreactor cells for hybrid artificial liver: transfection of glutamine synthetase into Chinese hamster ovary (CHO) cell. Enosawa S; Suzuki S; Fujino M; Amemiya H; Omasa T; Urayama S; Tanimura N; Suga K Cell Transplant; 1997; 6(5):537-40. PubMed ID: 9331509 [TBL] [Abstract][Full Text] [Related]
16. Effects of glutamine and asparagine on recombinant antibody production using CHO-GS cell lines. Xu P; Dai XP; Graf E; Martel R; Russell R Biotechnol Prog; 2014; 30(6):1457-68. PubMed ID: 25079388 [TBL] [Abstract][Full Text] [Related]
17. Application of CRISPR/Cas9 Genome Editing to Improve Recombinant Protein Production in CHO Cells. Grav LM; la Cour Karottki KJ; Lee JS; Kildegaard HF Methods Mol Biol; 2017; 1603():101-118. PubMed ID: 28493126 [TBL] [Abstract][Full Text] [Related]
18. A high-yielding CHO transient system: coexpression of genes encoding EBNA-1 and GS enhances transient protein expression. Daramola O; Stevenson J; Dean G; Hatton D; Pettman G; Holmes W; Field R Biotechnol Prog; 2014; 30(1):132-41. PubMed ID: 24106171 [TBL] [Abstract][Full Text] [Related]
19. CHOK1SV GS-KO SSI expression system: A combination of the Fer1L4 locus and glutamine synthetase selection. Feary M; Moffat MA; Casperson GF; Allen MJ; Young RJ Biotechnol Prog; 2021 Jul; 37(4):e3137. PubMed ID: 33609084 [TBL] [Abstract][Full Text] [Related]
20. Methionine sulfoximine supplementation enhances productivity in GS-CHOK1SV cell lines through glutathione biosynthesis. Feary M; Racher AJ; Young RJ; Smales CM Biotechnol Prog; 2017 Jan; 33(1):17-25. PubMed ID: 27689785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]